Paraoxonase 1 gene polymorphisms and dementia in humans

Neuroscience Letters

Volumn 358, Issue 1, 2004, Pages 41-44

  Helbecque, Nicole ^a   Cottel, Dominique ^a   Codron, Valérie ^a   Berr, Claudine ^b   Amouyel, Philippe ^a,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b Montpellier 1 University   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Case control study; Dementia; Esterases; Polymorphism (genetics)

Indexed keywords

APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMENTIA; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENETIC RISK; HETEROZYGOTE; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DEMENTIA; FEMALE; GENOTYPE; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 1542345607     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.100     Document Type: Article

References (19)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
2. Amouyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:1996;203-205.
3. Bar K.J., Franke S., Wenda B., Muller S., Kientsch-Engel R., Stein G., Sauer H. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol. Aging. 24:2003;333-338.
4. Combarros O., Alvarez-Arcaya A., Sanchez-Guerra M., Infante J., Berciano J. Candidate gene association studies in sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 14:2002;41-54.
5. Dantoine T.F., Drouet M., Debord J., Merle L., Cogne M., Charmes J.P. Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Ann. N. Y. Acad. Sci. 977:2002;239-244.
6. Deakin S., Leviev I., Brulhart Meynet M.C., James R.W. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role in vivo for polymorphic position -107 implicating the transcription factor Sp1. Biochem. J. 372:2003;643-649.
7. de la Torre J.C. Vascular basis of Alzheimer's pathogenesis. Ann. N. Y. Acad. Sci. 977:2002;196-215.
8. Frank A., Diez-Tejedor E., Bullido M.J., Valdivieso F., Barreiro P. APOE genotype in cerebrovascular disease and vascular dementia. J. Neurol. Sci. 203-204:2002;173-176.
9. in t' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345:2001;1515-1521.
10. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. J. Neurol. Sci. 203-204:2002;29-34.
11. Leviev I., James R.W. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol. 20:2000;516-521.
12. Leviev I., Righetti A., James R.W. Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J. Mol. Med. 79:2001;457-463.
13. Mackness M.I., Mackness B., Durrington P.N., Fogelman A.M., Berliner J., Lusis A.J., Navab M., Shih D., Fonarow G.C. Paraoxonase and coronary heart disease. Curr. Opin. Lipidol. 9:1998;319-324.
14. MacLean C.J., Morton N.E. Estimation of myriad haplotype frequencies. Genet. Epidemiol. 2:1985;263-272.
15. Paragh G., Balla P., Katona E., Seres I., Egerhazi A., Degrell I. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci. 252:2002;63-67.
16. Pola R., Gaetani E., Flex A., Gerardino L., Aloi F., Flore R., Serricchio M., Pola P., Bernabei R. Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population. Dement. Geriatr. Cogn. Disord. 15:2003;88-91.
17. Rhodin J., Thomas T., Bryant M., Sutton E.T. Animal model of Alzheimer-like vascular pathology and inflammatory reaction. Ann. N. Y. Acad. Sci. 903:2000;345-352.
18. Scacchi R., Gambina G., Martini M.C., Broggio E., Vilardo T., Corbo R.M. Different pattern of association of paraoxonase Gln192→Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease. Neurosci. Lett. 339:2003;17-20.
19. Sodeyama N., Yamada M., Itoh Y., Suematsu N., Matsushita M., Otomo E., Mizusawa H. No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease. Neurology. 53:1999;1146-1148.